Skip to main content
icon for Casos de sarampo nos EUA até 30 de abril?

Casos de sarampo nos EUA até 30 de abril?

icon for Casos de sarampo nos EUA até 30 de abril?

Casos de sarampo nos EUA até 30 de abril?

Ended: abr 30

jul 31

dez 31

Ended: abr 30

jul 31

dez 31

$479,297 Vol.

30 abr 2026
Polymarket

$479,297 Vol.

Polymarket

1750

$21,777 Vol.

Sim

1775

$39,332 Vol.

Sim

1800

$168,010 Vol.

Não

1900

$74,279 Vol.

Não

1850

$27,965 Vol.

Não

2000

$57,355 Vol.

Não

1950

$36,078 Vol.

Não

2100

$18,603 Vol.

Não

2200

$35,898 Vol.

Não

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$479,297
Data de Término
30 abr 2026
Mercado Aberto
Apr 16, 2026, 10:34 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Resultado proposto: Sim

Sem contestação

Resultado final: Sim

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$479,297
Data de Término
30 abr 2026
Mercado Aberto
Apr 16, 2026, 10:34 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Resultado proposto: Sim

Sem contestação

Resultado final: Sim

Relacionado

icon for Haverá pelo menos 2300 casos de sarampo nos EUA até 31 de julho de 2026?

Haverá pelo menos 2300 casos de sarampo nos EUA até 31 de julho de 2026?

84%
Sim
icon for Haverá pelo menos 3.000 casos de sarampo nos EUA em 2026?

Haverá pelo menos 3.000 casos de sarampo nos EUA em 2026?

87%
Sim
icon for Haverá pelo menos 1800 casos de ciclosporíase nos EUA até 31 de julho de 2026?

Haverá pelo menos 1800 casos de ciclosporíase nos EUA até 31 de julho de 2026?

95%
Sim

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 30 de abril?" is a prediction market on Polymarket with 9 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "1750" at 100%, followed by "1775" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Casos de sarampo nos EUA até 30 de abril?" has generated $479.3K in total trading volume since the market launched on Mar 24, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Casos de sarampo nos EUA até 30 de abril?," browse the 9 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 30 de abril?" is "1750" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "1775" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 30 de abril?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.